Comparison between De Neers Tools IPO and Remus Pharmaceuticals IPO.
De Neers Tools IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Remus Pharmaceuticals IPO is a SME Bookbuilding proposed to list at NSE SME.
| De Neers Tools IPO | Remus Pharmaceuticals IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Share India Capital Services Pvt.Ltd. Khambatta Securities Ltd. | Beeline Capital Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | Share India Securities Ltd. | Sunflower Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of De Neers Tools IPO is up to ₹21.83 Cr whereas the issue size of the Remus Pharmaceuticals IPO is up to ₹45.29 Cr. The final issue price of De Neers Tools IPO is ₹101.00 per share and of Remus Pharmaceuticals IPO is ₹1,229.00 per share.
| De Neers Tools IPO | Remus Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹95.00 per share | ₹1,150.00 per share |
| Issue Price (Upper) | ₹101.00 per share | ₹1,229.00 per share |
| Issue Price (Final) | ₹101.00 per share | ₹1,229.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | 100 shares |
| Fresh Issue Size | 21,61,200 shares | 3,68,500 shares |
| Fresh Issue Size (Amount) | up to ₹21.83 Cr | up to ₹45.29 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 21,61,200 shares | 3,68,500 shares |
| Issue Size Total (Amount) | up to ₹21.83 Cr | up to ₹45.29 Cr |
De Neers Tools IPO opens on Apr 28, 2023, while Remus Pharmaceuticals IPO opens on May 17, 2023. The closing date of De Neers Tools IPO and Remus Pharmaceuticals IPO is May 03, 2023, and May 19, 2023, respectively.
| De Neers Tools IPO | Remus Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | May 16, 2023 | |
| Issue Open | Apr 28, 2023 | May 17, 2023 |
| Issue Close | May 03, 2023 | May 19, 2023 |
| Basis Of Allotment (Tentative) | May 08, 2023 | May 24, 2023 |
| Initiation of Refunds (Tentative) | May 09, 2023 | May 25, 2023 |
| Credit of Share (Tentative) | May 10, 2023 | May 26, 2023 |
| Listing date (Tentative) | May 11, 2023 | May 29, 2023 |
| Anchor Lockin End date 1 | Jun 23, 2023 | |
| Anchor Lockin End date 2 | Aug 22, 2023 |
De Neers Tools IPO P/E ratio is , as compared to Remus Pharmaceuticals IPO P/E ratio of 21.09.
| De Neers Tools IPO | Remus Pharmaceuticals IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 91.14 | 92.82 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 68.37 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 21.09 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹86.92 Cr. | ₹181.03 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 71.44 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 69.99 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.03 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹7.97 | ₹33.86 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 21.17 | 52.64 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the De Neers Tools IPO Retail Individual Investors (RII) are offered 7,57,200 shares while in Remus Pharmaceuticals IPO retail investors are offered 7,57,200 shares. Qualified Institutional Buyers (QIB) are offered 10,78,800 shares in De Neers Tools IPO and 73,700 shares in Remus Pharmaceuticals IPO.
| De Neers Tools IPO | Remus Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,10,500 shares | |
| Market Maker Reservation | 1,15,200 shares | 19,500 shares |
| QIB | 10,78,800 shares | 73,700 shares |
| NII | 3,25,200 shares | 55,300 shares |
| RII | 7,57,200 shares | 1,29,000 shares |
| Employee | ||
| Others | ||
| Total | 21,61,200 shares | 3,68,500 shares |
De Neers Tools IPO subscribed 15.04x in total, whereas Remus Pharmaceuticals IPO subscribed 57.21x.
| De Neers Tools IPO | Remus Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | 3.72x | 10.75x |
| NII (times) | 60.16x | 229.31x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 11.88x | 49.81x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 15.04x | 57.21x |
